-
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
-
2022-501606-35-01
11
2024-02-21
Platinum-sensitive epithelial ovarian, fallopian tube, or primary
peri
-
2022-501890-38-00
4
2024-02-16
acute ischemic stroke
-
2023-505604-32-00
5
2024-01-24
Non small cell lung cancer (NSCLC)
-
2022-502660-20-00
5
2024-01-23
Follicular lymphoma
-
2022-503126-12-01
5
2024-01-05
Hypoparathyroidism
-
2023-503920-14-00
5
2024-01-02
Non-Small Cell Lung Cancer (NSCLC)
-
2022-501220-14-00
4
2023-10-17
epithelial ovarian, primary peritoneal, or fallopian tube cancer
-
2022-502959-54-00
5
2023-09-26
Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Ep
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2024-520006-19-00
6
2021-12-15
Non-muscle invasive bladder cancer
-
2025-523739-20-00
5
2026-05-14
Hypercholesterolemia
-
2025-522979-29-00
5
2026-04-30
Acute myeloid leukemia
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2024-520444-42-00
5
2026-04-15
Overweight or obesity, and knee osteoarthritis
-
2024-520445-23-00
5
2026-04-15
Overweight or obesity, and knee osteoarthritis
-
2023-509220-17-00
7
2026-04-10
Metastatic solid tumors
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2024-517490-24-00
4
2026-03-31
Small Cell Lung Cancer
-
2023-504957-11-00
5
2026-03-24
Metastatic castration resistant prostate cancer
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2025-523141-10-00
4
2026-03-20
Active Psoriatic Arthritis
-
2025-523075-32-00
5
2026-03-09
chronic kidney disease